Using cold gel packs to reduce itching in burn patients
The Effect of Cold Gel Pack Application on Itching in Burn Patients in the Maturation Stage: A Randomized Controlled Study
This study tests if using cold gel packs can help burn patients feel less itchy while their wounds heal.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Marmara University Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Istanbul) |
| Trial ID | NCT06334679 on ClinicalTrials.gov |
What this trial studies
This study investigates the impact of cold gel pack applications on itching experienced by burn patients during the maturation stage of wound healing. It employs a randomized controlled design, assigning participants to either a treatment group receiving cold gel packs or a control group receiving standard care. Data will be collected using validated assessment tools to measure itching severity, frequency, and duration. The goal is to determine if cold therapy can effectively alleviate itching in this patient population.
Who should consider this trial
Good fit: Ideal candidates are adults aged over 18 with 1st or 2nd degree burns covering 15-25% of their body, currently experiencing itching in the maturation phase of healing.
Not a fit: Patients with cold sensitivity, certain burn locations, or underlying conditions that may complicate treatment will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce itching and improve the quality of life for burn patients during their recovery.
How similar studies have performed: While the specific application of cold gel packs in this context may be novel, similar studies have shown that cold applications can help manage itching in various conditions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Burn percentage is between 15-25% and 1st or 2nd degree burn areas are in the maturation phase (BatesJensen Wound Assessment Tool Scale score=1-13), * Describing itching in burn wounds in the last 24 hours, * Over 18 years of age, * Literate, * Oriented to person, place and time, * Having no vision, speech or communication problems, * Do not have any skin disease other than burns, * Patients whose vital signs are within physiological limits (Pulse: 60-100/min, Temperature: average 37 degrees Celsius, respiration 12-16/min, Blood Pressure: average 120/80). Exclusion Criteria: * Cold sensitivity/allergy, * Perineum, neck and inner wrist burn areas * Hypertrophic scar area, * Burn infection * Raynaud's disease, * Use of aspirin, anticoagulants, non-steriod anti-inflammatory drugs, * Evitamin and vasoactive agent use, * Peripheral vascular disease, * Connective tissue disease, * Diabetic neuropathy, * Use of a medication that will cause itching, * Patients participating in another study conducted at the clinic * Applying medical treatment in addition to the clinical routine due to itching, * Due to the fact that he was discharged in a shorter period of time than the average hospitalization day, the research process failure to complete, * Failure to comply with the monitoring process and conditions of the research, * It was determined as the person wanting to leave the study voluntarily.
Where this trial is running
Istanbul
- Kartal Dr.Lütfi Kırdar City Hospital — Istanbul, Turkey (Recruiting)
Study contacts
- Study coordinator: Zeynep Ersoz
- Email: zeynepersoz08@gmail.com
- Phone: 05553496718
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.